Sequential management of postmenopausal health and osteoporosis: An update
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sequential management of postmenopausal health and osteoporosis: An update
Authors
Keywords
-
Journal
MATURITAS
Volume 177, Issue -, Pages 107846
Publisher
Elsevier BV
Online
2023-09-13
DOI
10.1016/j.maturitas.2023.107846
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
- (2023) Teerapat Tutaworn et al. OSTEOPOROSIS INTERNATIONAL
- Romosozumab and antiresorptive treatment: the importance of treatment sequence
- (2022) Felicia Cosman et al. OSTEOPOROSIS INTERNATIONAL
- Raloxifene Use After Denosumab Discontinuation Partially Attenuates Bone Loss in the Lumbar Spine in Postmenopausal Osteoporosis
- (2022) Namki Hong et al. CALCIFIED TISSUE INTERNATIONAL
- Risk of breast cancer with HRT depends on therapy type and duration
- (2022) Helen Saul et al. BMJ-British Medical Journal
- Mortality after Sustaining Skeletal Fractures in Relation to Age
- (2022) Camilla Bergh et al. Journal of Clinical Medicine
- Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis
- (2022) T. Liu et al. CLIMACTERIC
- Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults
- (2022) Meryl S. LeBoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D Deficiency Increases Mortality Risk in the UK Biobank
- (2022) Joshua P. Sutherland et al. ANNALS OF INTERNAL MEDICINE
- Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons
- (2022) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Menopause, wellbeing and health: A care pathway from the European Menopause and Andropause Society
- (2022) Irene Lambrinoudaki et al. MATURITAS
- Denosumab Discontinuation and the Rebound Phenomenon: A Narrative Review
- (2021) Athanasios D. Anastasilakis et al. Journal of Clinical Medicine
- Fezolinetant in the treatment of vasomotor symptoms associated with menopause
- (2021) Herman Depypere et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide
- (2021) Angelica Lindén Hirschberg et al. MATURITAS
- Update on Approved Osteoporosis Therapies Including Combination and Sequential Use of Agents
- (2021) Dominik Saul et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS
- (2021) Athanasios D Anastasilakis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
- (2020) Pauline M. Camacho et al. Endocrine Practice
- Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
- (2020) S. Rozenberg et al. OSTEOPOROSIS INTERNATIONAL
- Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS
- (2020) Elena Tsourdi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety of oral bisphosphonates in moderate‐to‐severe chronic kidney disease: a bi‐national cohort analysis
- (2020) Danielle E. Robinson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
- (2019) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness
- (2019) David F. Archer et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Menopause: Women should not suffer in silence
- (2019) Margaret Rees et al. MATURITAS
- Bazedoxifene for the treatment of osteoporosis
- (2019) Maria P. Yavropoulou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effects of ospemifene on bone in postmenopausal women
- (2019) T. J. de Villiers et al. CLIMACTERIC
- Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromsø Study
- (2019) D. Alarkawi et al. OSTEOPOROSIS INTERNATIONAL
- Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures
- (2019) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and meta-analysis
- (2018) Andreas Fontalis et al. Expert Opinion On Drug Safety
- Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial
- (2018) Piet Geusens et al. JOURNAL OF BONE AND MINERAL RESEARCH
- ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
- (2018) Henry G Bone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dietary intake and age at natural menopause: results from the UK Women’s Cohort Study
- (2018) Yashvee Dunneram et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials
- (2018) James A. Simon et al. JOURNAL OF WOMENS HEALTH
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study
- (2018) E Michael Lewiecki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause
- (2018) Colton Biehl et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Risk of subsequent fracture after prior fracture among older women
- (2018) A. Balasubramanian et al. OSTEOPOROSIS INTERNATIONAL
- Treatment Sequence Matters: Anabolic and Antiresorptive Therapy for Osteoporosis
- (2017) Felicia Cosman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
- (2017) Bente L Langdahl et al. LANCET
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
- (2016) Robert A Adler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)
- (2016) J. N. Tsai et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
- (2016) P. D. Miller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The effect of sequential therapy for postmenopausal women with osteoporosis
- (2016) Shenghan Lou et al. MEDICINE
- Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel
- (2016) Salvatore Caruso et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?
- (2016) Shari S. Bassuk et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Menopause Management — Getting Clinical Care Back on Track
- (2016) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?
- (2015) D. Edwards et al. CLIMACTERIC
- Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey
- (2015) R. E. Nappi et al. CLIMACTERIC
- Associations of Menopausal Vasomotor Symptoms with Fracture Incidence
- (2015) Carolyn J. Crandall et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
- (2015) Benjamin Z Leder et al. LANCET
- Update on management of genitourinary syndrome of menopause: A practical guide
- (2015) Santiago Palacios et al. MATURITAS
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial
- (2014) Benjamin Z. Leder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
- (2014) JoAnn V. Pinkerton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genitourinary syndrome of menopause
- (2014) David J. Portman et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
- (2013) Elizabeth Shane et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A single-dose study of denosumab in patients with various degrees of renal impairment
- (2012) Geoffrey A Block et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor and Cyclin D1
- (2011) J. S. Lewis-Wambi et al. MOLECULAR PHARMACOLOGY
- Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy
- (2009) David L Kendler et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now